Connection
Dale Terasaki to Patient Readmission
This is a "connection" page, showing publications Dale Terasaki has written about Patient Readmission.
|
|
Connection Strength |
|
|
|
|
|
0.146 |
|
|
|
-
Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 11 22; 17(1):64.
Score: 0.146